Movement Disorders Associated With the Serotonin Selective Reuptake Inhibitors
The Journal of Clinical PsychiatryPublished 15 October 1996
Raphael J. Leo
Citations360
SJR quartileQ1
SJR score1.49
SNIP1.38
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
SSRI-induced extrapyramidal symptoms are probably related to agonism of serotonergic input to dopaminergic pathways within the CNS and several patient-dependent and pharmacokinetic variables may determine the likelihood that EPS will emerge.
Abstract
SSRI-induced EPS are probably related to agonism of serotonergic input to dopaminergic pathways within the CNS. Several patient-dependent and pharmacokinetic variables may determine the likelihood that EPS will emerge. Although these side effects are infrequent, clinicians should be alert to the possibility of their occurrence.
Keywords
Medicine